Explore our export-ready bulk powders, specialized actives, and nutraceutical finished formulations produced under strict Health Canada Site License and cGMP standards.
The global dietary supplement and natural health product (NHP) market has shifted decisively toward verifiable quality, stringent regulatory compliance, and standardized botanical actives. For corporate procurement managers, brand owners, and pharmaceutical distributors, identifying a reliable CE Certified Herbal Extracts Manufacturer & Factory requires looking far beyond basic price-per-kilogram quotes. Modern international markets demand comprehensive batch-to-batch consistency, rigorous analytical assay validation, low solvent residue, and full regulatory dossier support.
Herbal extracts present unique manufacturing complexities due to natural variation in raw botanical biomass, potential heavy metal accumulation, pesticide carryover, and compound degradation during extraction. As a premier Canadian contract manufacturer with over 25 years of operational excellence, NutraLab Canada Corp. integrates pharmaceutical-grade manufacturing protocols, Health Canada Site Licensing, and cGMP compliance to deliver active plant extracts and finished dosage forms that satisfy strict European CE regulatory frameworks, Health Canada NPN guidelines, and US FDA requirements.
Our integrated manufacturing facility in Scarborough, Ontario, operates under strict regulatory oversight, offering complete single-source contract manufacturing services from botanical extraction to finished shelf-ready packaging.
Our facility holds an active Health Canada Site License and maintains strict adherence to cGMP (21 CFR Part 111) standards. Every production run undergoes complete batch record audit trail verification and quality release.
Consolidate your multi-SKU product lines under one roof. We specialize in Softgels, Compressed Tablets, Two-Piece Hard Capsules, Gummy Formulations, Liquid Syrups, and Uniform Powder Blending.
We streamline cross-border shipping into 35+ international markets by providing comprehensive dossier packages, including Certificate of Analysis (CoA), Certificate of Free Sale (CFS), and NPN regulatory licensing assistance.
Prevent intermediate contamination and delay. Our integrated packaging lines support HDPE bottling, induction sealing, blister thermoforming, powder/liquid sachets, cartoning, and customized combo packs.
To guarantee compliance with CE, European Pharmacopoeia (EP), and United States Pharmacopeia (USP) limits, our quality assurance protocols utilize state-of-the-art analytical testing methods at every stage of production.
| Quality Parameter | Analytical Methodology | Acceptance Criteria / Standard | NutraLab QA Impact |
|---|---|---|---|
| Active Marker Compound Quantification | High-Performance Liquid Chromatography (HPLC) / UV-Vis | Assay range 95.0% – 105.0% of label claim | Guarantees bio-active potency stability across shelf life. |
| Heavy Metal Contaminants | Inductively Coupled Plasma Mass Spectrometry (ICP-MS) | Pb < 0.5 ppm, Cd < 0.5 ppm, Hg < 0.1 ppm, As < 1.0 ppm | Ensures absolute compliance with strict European CE/EFSA safety limits. |
| Pesticide Residue Screen | GC-MS/MS & LC-MS/MS Multi-Residue Analysis | Conforms to EP 2.8.13 & USP <561> limits (>400 screening compounds) | Prevents agricultural chemical contamination in raw botanicals. |
| Residual Solvent Analysis | Headspace Gas Chromatography (HS-GC) | EP 2.4.24 / ICH Q3C Guidelines (Class 1, 2, 3 solvent screening) | Validates green extraction techniques with zero toxic solvent carryover. |
| Microbial & Pathogen Limits | Rapid Automated Micro Screening / USP <2021/2022> | Total Aerobic < 10^3 CFU/g, Yeast & Mold < 10^2 CFU/g, Absent Salmonella/E.coli | Prevents microbiological contamination in finished dosage units. |
As global consumer expectations evolve toward transparency and scientific validation, corporate procurement strategies must adapt to key macro-trends reshaping the botanical extract supply chain.
Procurement professionals are moving rapidly away from unstandardized plant powders toward extract ratios verified for specific marker compounds (e.g., 50% Phosphatidic Acid from Soy Extract, 99% Pure DL-Methionine, or specific High-Fulvic Acid Shilajit). Standardized compounds allow precise formulation dosing, predictable therapeutic outcomes, and cleaner consumer labeling.
Traditional solvent extraction using harsh chemicals (toluene, hexane) is being systematically phased out in favor of Supercritical CO2 Extraction, Subcritical Water Extraction, and Enzymatic Hydrolysis. Advanced delivery systems, such as phytosomes and nano-emulsified marine peptides, are being favored for their dramatically improved intestinal absorption rates.
To combat species substitution and adulteration in the botanical trade, top-tier international brands require genomic verification (DNA barcoding) of raw botanical materials before processing. Complete supply chain traceability from farm-level harvest to final finished container is becoming a mandatory requirement for CE and North American distribution.
Consumer demand for plant-based, non-GMO, Halal, and allergen-free dosage forms continues to surge. Procurement teams are prioritizing manufacturers capable of offering HPMC vegetarian capsules, pectin-based gummy formulations, and organic-certified excipient binders to support clean-label product claims.
Modern nutraceutical manufacturing blends traditional herbal knowledge with cutting-edge biopharmaceutical engineering. Key technological innovations driving factory production standards include:
Enzymatic hydrolysis allows complex macro-molecules (such as native collagen or plant proteins) to be broken down into low-molecular-weight bioactive peptides (e.g., Hydrolyzed Marine Collagen Peptides < 2000 Daltons). This targeted cleavage drastically increases gastrointestinal bio-accessibility and functional efficacy.
Active phytocompounds sensitive to gastric acid oxidation or possessing harsh organoleptic profiles (such as TUDCA, Shilajit, or concentrated Maca extracts) are subjected to fluid-bed micro-encapsulation. This preserves active potency and enables controlled, enteric intestinal release.
Achieving uniform compressibility and flowability in complex high-herb tablet formulations requires precision fluid-bed wet granulation technology. This eliminates capping, friability issues, and batch weight variation during high-speed tableting runs.
Direct responses to critical operational, regulatory, and logistics queries encountered during OEM/ODM contract manufacturing evaluations.
In the context of European health product distribution, CE certification alongside EU Regulation (EC) No 178/2002 and Novel Food Regulation (EU) 2015/2283 confirms that the botanical manufacturing facility complies with essential European health, safety, and environmental protection standards. NutraLab Canada supports European buyers by providing complete technical dossiers, heavy metal/microbial compliance validation, and trace chemical documentation required to obtain seamless European market entry.
Minimum order quantities depend directly on the chosen dosage form and packaging specifications. Standard minimum runs typically start at 100,000 units for compressed tablets or hard capsules, 300,000 units for specialized softgel encapsulation, and 1,000 kg for bulk powder blends. Our technical team works closely with brand owners to establish realistic production batches tailored to commercial scale-up plans.
We mandate standardized raw botanical materials verified via HPLC or UV-Vis assay testing prior to batch compounding. Our automated blending, encapsulation, and tableting suites maintain tight in-process statistical weight, hardness, and disintegration checks every 15–30 minutes during commercial manufacturing runs.
A standard new OEM project moves through six structured phases: technical consultation (Week 1), formulation R&D & sample approval (Weeks 2-3), regulatory NPN/dossier review (Weeks 3-5), raw material staging (Weeks 5-7), manufacturing & QC release (Weeks 7-9), and final packaging & international shipping (Weeks 9-10). Repeat order lead times are significantly shorter, typically completing within 4 to 6 weeks.
Yes. Our dedicated in-house regulatory affairs team manages Natural Product Number (NPN) applications directly with Health Canada. We also prepare complete export documentation packages—including Certificate of Analysis (CoA), Certificate of Free Sale (CFS), Good Manufacturing Practice (GMP) Certificates, and BSE/TSE-Free Statements—to support customs clearance in over 35 destination countries.
Absolutely. Bulk manufactured product never leaves our controlled cGMP environment prior to final primary and secondary packaging. We offer full in-house automated bottling (HDPE/PET/Glass), induction inner sealing, tamper-evident neck banding, blister thermoforming, single-serve powder/liquid sachets, cartoning, and serialized outer master case packing.
We provide ICH-compliant real-time and accelerated stability testing capabilities (40°C / 75% RH). Samples are monitored at scheduled intervals (3, 6, 12, 24, and 36 months) for active marker potency retention, physical integrity, disintegration time, and microbiological stability to establish defensible expiry dating.
Whether you require custom formulation development, contract softgel encapsulation, or large-scale bulk powder blending, NutraLab Canada delivers certified manufacturing precision backed by 25 years of global market leadership.
Send an Inquiry
